Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (221-230 of 326) with videos related to

Pageof 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T Podany, Yajing Bao, Susan Swindells, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infectionThomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 27, 2018
Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasmaLauren R Cirrincione, Sujan Dilly Penchala, Kimberly K Scarsi, et al.
Ebiomedicine|November 13, 2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trialHonghu Liu, Yan Wang, Yilan Huang, et al.
Addiction Science & Clinical Practice|January 10, 2024
Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related careElena M Soyer, Madeline C Frost, Olivia V Fletcher, et al.
HIV Medicine|May 12, 2015
Pharmacokinetics of tenofovir during pregnancy and postpartumB M Best, S Burchett, H Li, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary FibrosisTim J M Wallis, Magdalena Minnion, Anna Freeman, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2016
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary siteYiying Huang, Md Tozammel Hoque, Mohammad-Ali Jenabian, et al.
Science Advances|September 5, 2025
Synaptic imbalance and increased inhibition impair motor function in SMAEmily V Fletcher, Joshua I Chalif, Travis M Rotterman, et al.
The Journal of Infectious Diseases|July 7, 2000
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adultsJ M Jacobson, I Lowy, C V Fletcher, et al.
Pageof 33

Showing results (221-230 of 326) with videos related to

Sort By:
Pageof 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T Podany, Yajing Bao, Susan Swindells, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infectionThomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 27, 2018
Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasmaLauren R Cirrincione, Sujan Dilly Penchala, Kimberly K Scarsi, et al.
Ebiomedicine|November 13, 2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trialHonghu Liu, Yan Wang, Yilan Huang, et al.
Addiction Science & Clinical Practice|January 10, 2024
Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related careElena M Soyer, Madeline C Frost, Olivia V Fletcher, et al.
HIV Medicine|May 12, 2015
Pharmacokinetics of tenofovir during pregnancy and postpartumB M Best, S Burchett, H Li, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary FibrosisTim J M Wallis, Magdalena Minnion, Anna Freeman, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2016
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary siteYiying Huang, Md Tozammel Hoque, Mohammad-Ali Jenabian, et al.
Science Advances|September 5, 2025
Synaptic imbalance and increased inhibition impair motor function in SMAEmily V Fletcher, Joshua I Chalif, Travis M Rotterman, et al.
The Journal of Infectious Diseases|July 7, 2000
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adultsJ M Jacobson, I Lowy, C V Fletcher, et al.
Pageof 33